PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis
Abstract
There are few tissue‐based biomarkers that can accurately predict prostate cancer (PCa) progression and aggressiveness. We sought to evaluate the clinical utility of prostate and breast overexpressed 1 (PBOV1) as a potential PCa biomarker.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 09, 2018
- Source ID
- 10.1002/pros.23499
Entities
People
- Guangjing Zhu
- Kenneth J. Pienta
- Linda M. S. Resar
- M. Craig Miller
- Mikhail Gorbounov
- Neil M Carleton
- Robert W. Veltri
Organizations
- Carnegie Mellon University
- Johns Hopkins University
- United States Department of Defense